Peptide Injections for Weight Loss: What Works Beyond GLP-1

Metabolic peptides support weight management through four distinct mechanisms: appetite and blood sugar regulation, growth hormone-mediated fat metabolism, mitochondrial efficiency, and muscle preservation during weight loss. For the many patients now taking GLP-1 medications, the last of these has become the most clinically important — because losing muscle alongside fat undermines the metabolic result you are trying to achieve.

Where GLP-1 medications fit

GLP-1 receptor agonists have transformed obesity medicine, and there is no reason to be coy about it: they work, often dramatically, for a condition that had few effective medical options. They slow gastric emptying, regulate appetite signaling in the brain, and improve insulin sensitivity.

But two realities have emerged with widespread use. First, a substantial portion of the weight lost on GLP-1 medications is lean mass, not fat — with published estimates commonly in the range of a quarter to 40 percent of total loss depending on the study and population. Muscle is metabolically expensive tissue; losing it lowers your resting metabolic rate and makes regain both more likely and harder to reverse. Second, when patients stop, weight regain is common — and if the tissue lost was muscle and the tissue regained is fat, body composition ends up worse than at baseline despite an unchanged scale weight.

That is the specific gap where peptides earn their place: not competing with GLP-1 medications, but protecting the quality of the loss.

The metabolic peptides

Tesamorelin: visceral fat

Tesamorelin is a growth hormone-releasing hormone analog with FDA approval, studied specifically for the reduction of visceral adipose tissue — the metabolically active fat surrounding abdominal organs, as distinct from the subcutaneous fat you can pinch.

The distinction matters medically. Visceral fat drives insulin resistance, systemic inflammation, and cardiovascular risk in a way subcutaneous fat does not; it also converts testosterone to estradiol via aromatase, worsening the hormonal environment in men. Tesamorelin is the most evidence-supported peptide option when central adiposity is the primary concern, and it is frequently the one I recommend to patients whose weight is “normal” but whose waist measurement is not.

CJC-1295 and Ipamorelin: preserving lean mass

Growth hormone supports lipolysis — the breakdown of stored fat for fuel — while simultaneously helping preserve lean tissue. That dual action is exactly what a patient in a caloric deficit needs, and exactly what is at risk during rapid GLP-1-mediated weight loss.

In practice, these peptides are increasingly used alongside GLP-1 medications rather than as alternatives: the GLP-1 drives the deficit, the growth hormone peptides help ensure the deficit is filled by fat rather than muscle. They also improve sleep, and poor sleep independently sabotages weight loss through effects on ghrelin, leptin, and insulin sensitivity. Full mechanism: CJC-1295 and Ipamorelin explained .

MOTS-c: mitochondrial efficiency

MOTS-c is a peptide encoded by mitochondrial rather than nuclear DNA, and it activates AMPK — the cellular energy sensor that also mediates much of the effect of exercise and metformin. Research associates it with improved insulin sensitivity, better glucose utilization, and increased metabolic flexibility, meaning the ability to switch efficiently between burning carbohydrate and fat.

Metabolic flexibility is an underappreciated driver of weight difficulty. Patients who have been metabolically inflexible for years feel terrible between meals, crash after carbohydrate, and cannot access stored fat efficiently — which makes any dietary approach miserable to sustain.

AOD-9604 and fragment peptides

AOD-9604 is a fragment of the growth hormone molecule isolated for its fat-metabolism activity without the growth-promoting effects of the full hormone. Human trial results have been mixed and less impressive than early enthusiasm suggested; I include it here for completeness and because patients ask, not as a primary recommendation. Honest assessment of the evidence is part of what you should expect from a peptide physician — see Are peptides safe? FDA rules and choosing a doctor

The peptides that address why weight is stuck

Frequently the limiting factor is not fat metabolism at all.

Untreated hypothyroidism makes weight loss nearly impossible and is regularly missed on a TSH-only panel; see peptides for thyroid health . Cortisol dysregulation drives visceral fat deposition and carbohydrate cravings directly; see peptides for adrenal function and stress. Low testosterone in men and the menopausal transition in women both shift body composition independently of calories — see the men’s  and women’s guides. Poor sleep and insulin resistance compound all of the above.

This is why a serious weight consultation is a metabolic and hormonal workup, not a prescription pad.

The workup

Before recommending anything, we test: complete thyroid panel including free T3, free T4, reverse T3, and antibodies; fasting insulin and HbA1c (fasting insulin identifies insulin resistance years before glucose rises, and is one of the most useful tests in this category); a full lipid panel; comprehensive metabolic panel; hs-CRP; cortisol rhythm; sex hormones; IGF-1; vitamin D, ferritin, and B12; and body composition assessment, because scale weight alone conceals the muscle-versus-fat question that determines whether a protocol is working.

Body composition tracking is non-negotiable in this category. A patient down eight pounds who has lost six of fat and two of muscle is succeeding. A patient down eight pounds who has lost four of each is not, regardless of what the scale says.

What a realistic protocol looks like

A typical plan combines nutritional strategy built around adequate protein — the single most important dietary variable for preserving muscle during loss — with resistance training two to four times weekly, sleep optimization, and correction of any hormonal or metabolic finding from the workup. Peptides are then selected against what remains: Tesamorelin where visceral fat dominates, GH peptides where muscle preservation and recovery matter, MOTS-c where insulin resistance and metabolic inflexibility are prominent.

Where a GLP-1 medication is appropriate, it may be part of the plan; peptides and GLP-1 medications are not mutually exclusive and are increasingly used together for the reasons above.

Expectations are set honestly. Peptides support a well-constructed program. They do not produce dramatic weight loss on their own, and any clinic advertising that they do is selling something other than medicine.

Why muscle preservation is the whole game

Patients underestimate this, so it is worth spelling out.

Muscle is the most metabolically demanding tissue you carry. It is also the primary site of glucose disposal — the tissue that pulls sugar out of your bloodstream after a meal. When you lose muscle, two things happen simultaneously: your resting metabolic rate falls, meaning you need fewer calories to maintain the same weight, and your capacity to handle carbohydrate worsens, meaning insulin resistance tends to progress rather than improve.

This is the mechanism behind the pattern almost every long-term dieter recognizes. Each round of weight loss that includes significant muscle loss leaves you needing to eat less than before to maintain the result. Regain then preferentially returns fat rather than the muscle that was lost. After several cycles, a patient at the same scale weight as a decade earlier has substantially worse body composition and metabolic health.

The clinical implication is direct: how you lose weight matters as much as how much. A protocol built around protein adequacy, resistance training, and — where appropriate — growth hormone peptides that support lean mass retention produces a metabolically different result from the same weight lost without them, even when the number on the scale is identical.

This is why body composition assessment is not optional in our program and why I regard “how much will I lose” as the less important question.

When weight loss stalls

Plateaus are predictable and have identifiable causes, most of which are not willpower.

• Metabolic adaptation: Energy expenditure falls with weight loss, partly from reduced body mass and partly from adaptive reductions in non-exercise activity. This is normal physiology and is addressed with strategy — periodic maintenance phases, adequate protein, and preserved muscle — rather than by cutting calories further, which accelerates the problem.
• Undiagnosed thyroid disease: Common, and commonly missed on a TSH-only panel.
• Cortisol dysregulation: Elevated evening cortisol drives visceral deposition and carbohydrate craving directly, and chronic under-recovery is itself a stressor. Patients aggressively dieting and training while sleeping poorly are frequently stuck for this reason.
• Sleep debt: Insufficient sleep raises ghrelin, lowers leptin, and impairs insulin sensitivity within days. It is one of the most reliable ways to make weight loss feel impossible.
• Untreated sleep apnea: Worth checking in anyone with central adiposity, snoring, or unrefreshing sleep.
• Inaccurate intake estimation: Not a moral failing and not usually deliberate — intake tracking drifts over weeks in nearly everyone, and a brief period of careful measurement frequently resolves the mystery.

The productive response to a plateau is reassessment: repeat labs, review sleep, review training, and re-examine whether the original protocol still matches the current physiology. The unproductive response — adding more compounds without asking why — is what I try to steer patients away from.

Safety

Growth hormone peptides are contraindicated in active malignancy and proliferative diabetic retinopathy, require caution in diabetes given effects on insulin sensitivity, and are not used in pregnancy or breastfeeding. Metabolic markers and IGF-1 are monitored throughout. Side effects in supervised use are generally limited to injection-site irritation and early fluid retention with GH peptides, which typically signals a dose adjustment.

At Patients Medical

Your one-hour evaluation with Dr. Rashmi Gulati, MD ($600) covers weight history, prior attempts, medications, sleep, training, and dietary pattern, followed by comprehensive testing through Labcorp or Quest. You receive an explanation of your metabolic picture and a plan built on it. Peptide costs are additional and vary with the type and amount prescribed. Follow-up visits track labs and body composition, with fees depending on visit length and treatment provided.

The role of GLP-1 medications in our practice

Patients sometimes assume an integrative practice will steer them away from GLP-1 medications. We do not.

These are effective drugs for a condition where effective options were scarce, and declining to use them on philosophical grounds would not serve patients well. Where a GLP-1 medication is clinically appropriate, it may be part of the plan.

What we add is the surrounding care that determines whether the result holds: adequate protein and resistance training to protect lean mass, peptides supporting muscle preservation and body composition, correction of the thyroid, hormonal, and metabolic findings that the workup identifies, and body composition tracking so we know what kind of weight is actually being lost.

We also plan for what happens afterward. Patients who improve their metabolic health, build muscle, and correct underlying hormonal issues during a period of GLP-1 use are in a substantially better position when they eventually taper than patients who lost weight and changed nothing else.

Frequently asked questions

Q. Are peptides better than semaglutide or tirzepatide?

A. They are different tools. GLP-1 medications are more powerful for appetite-driven weight loss; peptides address body composition, muscle preservation, visceral fat, and metabolic efficiency. Many patients benefit from both.

Q. Can I take peptides with my GLP-1 medication?

A. Frequently yes, and muscle preservation is a common reason to do so. This requires physician supervision and coordination.

Q. How much weight will I lose on peptides alone?

A. Peptides alone are not a weight-loss drug and I would not represent them as one. They support a program; they do not replace one.

Q. Will peptides help me keep weight off after stopping a GLP-1?

A. Preserving muscle during loss improves your metabolic position for maintenance. Nothing guarantees against regain without sustained behavioral change.

Q. Do peptides help with belly fat specifically?

A. Tesamorelin has the strongest evidence for visceral abdominal fat specifically. Cortisol and hormone correction also matter substantially for midsection fat.

Want a metabolic workup rather than another prescription?

Learn about peptide therapy in NYC at Patients Medical, 1148 Fifth Avenue, Suite 1B, New York, NY 10128. Call (212) 794-8800 or start with a free 10-minute introductory call.

Medical disclaimer: educational content only; not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary; certain peptides are prescribed off-label or as compounded preparations.